Advertisement

In the midst of building its new facility in Billerica, Pharmalucence Inc. has received FDA approval to expand the allowed uses of its sulfur colloid injection (SCI) to include localization of lymph nodes in malignant melanoma patients.

Advertisement
Advertisement